Page last updated: 2024-11-03

1,2,5,8-tetrahydroxy anthraquinone and Nasopharyngeal Neoplasms

1,2,5,8-tetrahydroxy anthraquinone has been researched along with Nasopharyngeal Neoplasms in 1 studies

1,2,5,8-tetrahydroxy anthraquinone: structure in first source
quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, X1
Meng, R1
Yu, Z1
Mou, J1
Liu, S1
Sun, Z1
Zou, Z1
Wu, G1
Peng, G1

Other Studies

1 other study available for 1,2,5,8-tetrahydroxy anthraquinone and Nasopharyngeal Neoplasms

ArticleYear
Quinalizarin enhances radiosensitivity of nasopharyngeal carcinoma cells partially by suppressing SHP-1 expression.
    International journal of oncology, 2016, Volume: 48, Issue:3

    Topics: Anthraquinones; Apoptosis; Binding Sites; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferatio

2016